PT-141

VYTL Labs PT-141 is a synthetic research peptide supplied for laboratory and pre-clinical research use only, available in 10mg concentration. PT-141 (Bremelanotide analog) is a melanocortin receptor–targeting peptide that has been examined in research models involving melanocortin signaling pathways, receptor interaction dynamics, and neuroendocrine pathway analysis.

In controlled laboratory environments, PT-141 has been studied for its interaction with melanocortin receptors (MC receptors) and downstream signaling mechanisms associated with receptor activation models. This compound is provided to support analytical, exploratory, and comparative research involving melanocortin-related pathways.

Each vial is COA verified and independently tested to confirm purity and identity, supporting consistency, reproducibility, and reliability across research applications. VYTL Labs PT-141 is provided in research-grade quality and packaged to maintain stability and integrity during storage and handling.

For laboratory research use only. Not for human or veterinary consumption. This product is not FDA-approved and is supplied strictly for research purposes.